Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
40.82
+0.03 (0.07%)
Dec 24, 2024, 4:00 PM EST - Market closed
Kymera Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 87.56 | 78.59 | 46.83 | 72.83 | 34.03 | 2.93 | Upgrade
|
| Revenue Growth (YoY) | 86.92% | 67.84% | -35.71% | 114.00% | 1059.99% | - | Upgrade
|
| Cost of Revenue | 221.4 | 189.08 | 164.25 | 137.02 | 62.11 | 37.16 | Upgrade
|
| Gross Profit | -133.84 | -110.49 | -117.42 | -64.19 | -28.07 | -34.22 | Upgrade
|
| Selling, General & Admin | 61.43 | 55.04 | 43.83 | 36.35 | 18.23 | 7.98 | Upgrade
|
| Operating Expenses | 61.43 | 55.04 | 43.83 | 36.35 | 18.23 | 7.98 | Upgrade
|
| Operating Income | -195.27 | -165.53 | -161.26 | -100.53 | -46.3 | -42.21 | Upgrade
|
| Interest Expense | -0.24 | -0.2 | -0.18 | -0.18 | -0.12 | -0.05 | Upgrade
|
| Interest & Investment Income | 32.96 | 18.76 | 6.62 | 0.49 | 0.83 | 1.01 | Upgrade
|
| Pretax Income | -167.47 | -146.96 | -154.81 | -100.22 | -45.59 | -41.25 | Upgrade
|
| Net Income | -167.47 | -146.96 | -154.81 | -100.22 | -45.59 | -41.25 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 9.05 | - | Upgrade
|
| Net Income to Common | -167.47 | -146.96 | -154.81 | -100.22 | -54.64 | -41.25 | Upgrade
|
| Shares Outstanding (Basic) | 70 | 58 | 54 | 48 | 17 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 70 | 58 | 54 | 48 | 17 | 2 | Upgrade
|
| Shares Change (YoY) | 19.60% | 8.22% | 12.39% | 176.60% | 921.45% | 44.44% | Upgrade
|
| EPS (Basic) | -2.41 | -2.52 | -2.87 | -2.09 | -3.15 | -24.28 | Upgrade
|
| EPS (Diluted) | -2.41 | -2.52 | -2.87 | -2.09 | -3.15 | -24.28 | Upgrade
|
| Free Cash Flow | -148.2 | -137.31 | -155.92 | -130.54 | 79.03 | 17.37 | Upgrade
|
| Free Cash Flow Per Share | -2.13 | -2.35 | -2.89 | -2.72 | 4.56 | 10.23 | Upgrade
|
| Gross Margin | -152.85% | -140.59% | -250.76% | -88.13% | -82.48% | - | Upgrade
|
| Operating Margin | -223.00% | -210.62% | -344.37% | -138.03% | -136.05% | -1438.48% | Upgrade
|
| Profit Margin | -191.26% | -186.99% | -330.60% | -137.60% | -160.55% | -1405.79% | Upgrade
|
| Free Cash Flow Margin | -169.25% | -174.71% | -332.98% | -179.24% | 232.22% | 592.13% | Upgrade
|
| EBITDA | -190.49 | -163.47 | -159.48 | -99.03 | -45.24 | -41.78 | Upgrade
|
| EBITDA Margin | -217.55% | -207.99% | - | -135.97% | -132.93% | - | Upgrade
|
| D&A For EBITDA | 4.78 | 2.07 | 1.78 | 1.5 | 1.06 | 0.43 | Upgrade
|
| EBIT | -195.27 | -165.53 | -161.26 | -100.53 | -46.3 | -42.21 | Upgrade
|
| EBIT Margin | -223.00% | -210.62% | - | -138.03% | -136.05% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.